Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,481 to 1,500 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy. | Front Immunol | 2021 | 34603309 | PubTator, text mining | PubMed |
| CXCL5 Downregulation in Villous Tissue Is Correlated With Recurrent Spontaneous Abortion. | Front Immunol | 2021 | 34603292 | PubTator, text mining | PubMed |
| Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2021 | 34595140 | PubTator, text mining | PubMed |
| Evidence for the butyrate metabolism as key pathway improving ulcerative colitis in both pediatric and adult patients. | Bioengineered | 2021 | 34592880 | PubTator, text mining | PubMed |
| IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming. | Oncogenesis | 2021 | 34588424 | PubTator, text mining | PubMed |
| Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes. | Cell Rep | 2021 | 34587478 | PubTator, text mining | PubMed |
| Gene Therapy Approaches to Slow or Reverse Blindness From Inherited Retinal Degeneration: Growth Factors and Optogenetics. | Int Ophthalmol Clin | 2021 | 34584058 | PubTator, text mining | PubMed |
| Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium. | PLoS One | 2021 | 34582497 | PubTator, text mining | PubMed |
| Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade. | J Immunother Cancer | 2021 | 34580162 | PubTator, text mining | PubMed |
| Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma. | Clin Cancer Res | 2021 | 34580113 | PubTator, text mining | PubMed |
| Differential Regulation of Interferon Signaling Pathways in CD4+ T Cells of the Low Type-2 Obesity-Associated Asthma Phenotype. | Int J Mol Sci | 2021 | 34576307 | PubTator, text mining | PubMed |
| Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy. | Int J Mol Sci | 2021 | 34575965 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Characterization of a Discordant KMT2A/AFF1-Rearranged Infant Monozygotic Twin Pair. | Int J Mol Sci | 2021 | 34575904 | PubTator, text mining | PubMed |
| Molecular Mechanism and Pathways of Normal Human Parturition in Different Gestational Tissues: A Systematic Review of Transcriptome Studies. | Front Physiol | 2021 | 34566691 | PubTator, text mining | PubMed |
| Systemic inflammation alters the neuroinflammatory response: a prospective clinical trial in traumatic brain injury. | J Neuroinflammation | 2021 | 34563211 | PubTator, text mining | PubMed |
| NOX2-Deficient Neutrophils Facilitate Joint Inflammation Through Higher Pro-Inflammatory and Weakened Immune Checkpoint Activities. | Front Immunol | 2021 | 34557202 | PubTator, text mining | PubMed |
| CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells. | Mol Ther Oncolytics | 2021 | 34553036 | PubTator, text mining | PubMed |
| Structure of African Swine Fever Virus and Associated Molecular Mechanisms Underlying Infection and Immunosuppression: A Review. | Front Immunol | 2021 | 34552586 | PubTator, text mining | PubMed |
| MicroRNAs in IgA nephropathy. | Ren Fail | 2021 | 34547971 | PubTator, text mining | PubMed |
| Computational drug repositioning of atorvastatin for ulcerative colitis. | J Am Med Inform Assoc | 2021 | 34529084 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=75